Goodwin Procter, a national Am Law 50 firm, announced today that Karen A. Spindler has joined the firm’s San Francisco office as a partner in its Life Sciences Practice. She will focus on advising life sciences companies and investors on a variety of intellectual property transactions. Spindler joins Goodwin from Kirkland & Ellis where she was a partner in its Palo Alto and San Francisco offices.
At Goodwin, Spindler will represent biotech and pharmaceutical companies in transactions involving intellectual property assets. Spindler has considerable experience structuring and negotiating license, collaboration, co-development, supply and manufacturing agreements. She also counsels financial investors, including private equity funds and operating companies, on complex intellectual property issues arising in corporate transactions, including mergers, stock and asset purchases, divestitures, royalty agreements, leveraged buyouts, recapitalizations, bankruptcies and financing transactions.
Her clients have included Fortune 500 biopharmaceutical companies, semiconductor manufacturers and computer technology providers, as well as leading private equity funds.
“Karen’s broad range of experience, particularly in licensing and collaboration work, further strengthens Goodwin’s life sciences practice, both nationally and on the West Coast, as we continue to focus on assisting clients with high-end transactions,” said Kingsley Taft, national co-chair of the firm’s Life Sciences Practice. “Karen understands the collaborative approach we take for our life sciences clients, building teams that can meet the full range of needs for counsel on corporate, litigation, securities, M&A, licensing, FDA and patent issues.”
“Having an attorney of Karen’s caliber join our office adds even greater depth to our West Coast life sciences, technology and private equity practices,” added Bradley Bugdanowitz, chair of Goodwin’s San Francisco office. “With her expertise and market knowledge, Karen can provide innovative and strategic counsel to our growing West Coast and national client base.”
Spindler received her J.D. from Santa Clara University School of Law and her B.S. in biology from Stanford University. She is admitted to practice in California and was recently named a “Life Sciences Star” by Euromoney Legal Media Group for licensing and collaboration expertise in the life sciences industry.
She can be reached at 415.733.6058 or firstname.lastname@example.org.
Goodwin’s Life Sciences Practice includes more than 100 experienced life sciences attorneys and is recognized as one of the leading practices in the United States, having been recently named the 2013 U.S. News-Best Lawyers’ “Law Firm of the Year” in Biotechnology Law. Clients include more than 400 private and public life sciences companies, from start-ups to Fortune 100 corporations.
The firm’s San Francisco office opened in 2006 and includes approximately 40 lawyers who focus on technology, life sciences, private equity, leveraged finance, real estate and hospitality, patent litigation and complex business litigation.
About Goodwin Procter
Goodwin Procter LLP is a leading Global 100 law firm with offices in Boston, Hong Kong, London, Los Angeles, New York, San Diego, San Francisco, Silicon Valley and Washington, D.C. The firm provides corporate law and litigation services, with a focus on matters involving real estate, REITs and real estate capital markets; private equity; technology companies; financial institutions; intellectual property; products liability and mass torts; and securities litigation and white collar defense. Information may be found at www.goodwinprocter.com. Follow us on Twitter @GoodwinProcter.